[1]
2026. LOW-DOSE VERSUS STANDARD-DOSE RITUXIMAB IN VESICULOBULLOUS DISORDERS: A COMPARATIVE EFFECTIVENESS STUDY. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jul. 2026), 1638–1642.